Evidence map›Paper›PMID 32520445›Full record

ArticleHemodialysis international. International Symposium on Home Hemodialysis2020

Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients.

Shuo Yang, Qingyu Niu, Liangying Gan, Xiaobo Zhang, Lingxue Tu, Li Zuo

Open access · hybridAbstract read
In one paragraph

Article in Hemodialysis international. International Symposium on Home Hemodialysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Secondary Osteoporosis and Metabolic Bone Diseases.Journal of clinical medicine · 2022
    Review
  5. Effects of different routes of heparin on instant blood-mediated inflammatory reaction after portal vein islet transplantation.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shuo YangDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Qingyu NiuDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Liangying GanDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Xiaobo ZhangDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Lingxue TuDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Li ZuoDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Peking University · CNPeking University People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLong-term use of unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) causes bone loss and osteoporosis in patients not receiving hemodialysis. This study aimed to investigate the effect of UFH and LMWH on bone mineral density (BMD) in patients undergoing maintenance hemodialysis (MHD).

methodsPatients undergoing MHD using UFH or LMWH as anticoagulants were enrolled. BMD (in g/cm

findingsA total of 104 patients were enrolled and completed the baseline BMD test; 72 completed the test again 2 years later. Six patients were excluded because they used both UFH and LMWH. Although BMD decreased in some patients in the UFH group, a slight increase in the BMD was observed on an average in the LMWH group after 2 years. The mean change in BMD (in g/cm DISCUSSION: UFH might be associated with loss of lumbar spine BMD in patients undergoing MHD.

Indexed as

Bone DensityCohort StudiesFemaleHeparin, Low-Molecular-WeightHumansMaleMiddle AgedOsteoporosisProspective StudiesRenal DialysisHeparin, Low-Molecular-Weightbone mineral densityHemodialysisheparinlow-molecular-weight heparinosteoporosis

Identifiers

PMID32520445
PMCPMC7496178
OpenAlexW3033513577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.